Drug Shortage Report for INTUNIV XR
Report ID | 91467 |
Drug Identification Number | 02409135 |
Brand name | INTUNIV XR |
Common or Proper name | guanfacine hydrochloride extended-release tablets |
Company Name | TAKEDA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | Guanfacine |
Strength(s) | 4MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 Tablets / Bottle |
ATC code | C02AC |
ATC description | ANTIADRENERGIC AGENTS, CENTRALLY ACTING |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-08-13 |
Actual start date | |
Estimated end date | 2019-09-30 |
Actual end date | 2019-09-26 |
Shortage status | Resolved |
Updated date | 2019-09-27 |
Company comments | Shortage resolved as of 26Sep2019 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2019-09-27 | English | Compare |
v10 | 2019-09-26 | French | Compare |
v9 | 2019-09-26 | French | Compare |
v8 | 2019-09-26 | English | Compare |
v7 | 2019-08-15 | French | Compare |
v6 | 2019-08-15 | English | Compare |
v5 | 2019-08-15 | English | Compare |
v4 | 2019-08-14 | English | Compare |
v3 | 2019-08-13 | French | Compare |
v2 | 2019-08-13 | French | Compare |
v1 | 2019-08-13 | English | Compare |
Showing 1 to 11 of 11